strategies you can use the next day. The Precision in Clinical Trials (Zurich, Switzerland) summit will be a unique platform for the largest bio-pharmaceutical hub in the region to network and discuss collaboration to achieve their outsourcing and...
endpoint. The UHDRS is a comprehensive clinical rating scale developed by the Huntington Study Group to provide a uniform assessment of the clinical features and course of HD. It is comprised of motor, cognitive, behavioral, and functional...
to advance the biopharmaceutical industry so that first-rate pharmaceutical drugs can become widely accessible. For more information, visit www.innoventbio.com
Craft Telemedicine today announced the official launch of its innovative telemedicine platform that eliminates subscription models and empowers patients with unprecedented choice and transparency in their healthcare decisions. Unlike traditional...
Join The Hackett Group and functional and operations leaders to supercharge business change and performance, while leveraging AI for maximum impact. Prepare for Industry Headwinds and Enhance Operational Excellence in Pharma Over the next 5 years,...
Designed with and conducted by investigators across multiple sites in the United States, the study will assess the performance of VersaWrap in reducing postoperative complications such as tendon tethering. "Tendon injuries, especially those...
MIC+B12 injections that support metabolic health and energy production, as well as two new oral combination therapies: Metformin + Naltrexone + Topiramate and Naltrexone + Bupropion. Together, these offerings create a powerful portfolio of weight...
to treat NMIBC though the non-viral stimulation of a local immune response in the bladder, presenting a potentially transformative option for patients who otherwise face limited choices beyond radical cystectomy. About Non-Muscle Invasive Bladder...
exceptional achievements and innovations by Contract Research Organizations, recognizing CROs demonstrating outstanding performance, innovation, and leadership in delivering high-quality research and development services. The awards emphasize the...
High-Performance Liquid Phase Separations and Related Techniques - Waters Corporation (NYSE: WAT) today announced the release of the Alliance iS HPLC System Software version 2.0, a significant advancement that delivers comprehensive, end-to-end...
quality and value to clients, ensuring operational efficiency and compliance across various industries. For more information please visit, www.sobran.com
The agreement signifies a shared commitment to deploy Exobiosphere's Orbital High-Throughput Screening (OHTS) platform aboard Space Cargo Unlimited's BentoBox platform across several flights, with return-to-Earth capability enabled by ATMOS'...
dedicated to funding lung cancer research. About Boehringer Ingelheim in Oncology We have a clear aspiration – to transform the lives of people with cancer by delivering meaningful advances, with the ultimate goal of curing a range of cancers....
severe chronic rhinosinusitis with nasal polyps (CRSwNP) and coexisting asthma. In the trial, Dupixent® (dupilumab) outperformed Xolair® (omalizumab) on all primary and secondary efficacy endpoints of CRSwNP, and in all asthma-related endpoints....
Pharmaceuticals, Inc., headquartered in New Jersey, leads global clinical development and commercialization. For more information, visit www.mezzion.com.
the past year, we have been focused on building global scientific awareness and encouraging adoption of our chelator platform across the therapeutic radiopharmaceutical community," said Bill Cupelo, Chief Business Officer of Ratio. "We are proud to...
products, as well as making sustainable business decisions for the betterment of society and global health. For more information, please visit https://samsungbiologics.com/
81 percent had one prior LOT (range, 1−3), and 65 percent had progressed within 12 months of first-line treatment. More information on this trial can be found at https://www.clinicaltrials.gov/ (NCT: 04663347). About Epcoritamab: Epcoritamab is an...
in the generation of predictive human disease models is pleased to announce the launch of its modular iPSCore™ platform. iXCells’ mission is to empower life science researchers and patient foundations to advance personalized therapies and...
to delivering innovative therapies that help patients stay ahead of their disease.” ROS1+ NSCLC is a rare and aggressive form of lung cancer, accounting for approximately 2% of new NSCLC cases, or about 3,000 new diagnoses of advanced disease...
